Treatment of lipid disorders in obe- sity. Expert Rev Cardiovasc Ther 2011; 9: 1069-1080SerenaTonstad, Jean-PierreDesprés. (2011) Treatment of lipid disorders in obesity. Expert Review of Cardiovascular Therapy 9 , 1069-1080 /Tonstad S,Després JP.Treatment of lipid disorders in obe- sity....
This document is the revised version of the `Note for guidance on clinical investigation of medicinalproducts in the treatment of lipid disorders (CHMP/EWP/3020/03)'. It is intended to provide guidance for the evaluation of drugs in the treatment of lipid disorders and details the main regulato...
由欧洲药品管理局(EMA)发布的关于Guideline on clinical investigation of medicinal products in the treatment of lipid disorders(药品治疗脂质紊乱临床研究指南),来源于药智数据政策法规数据库。
Composition for treatment of inflammatory disorders A pharmaceutical composition for parenteral administration, comprising liposomes composed of non-charged vesicle-forming lipids, including up to 20 mole percent of an amphipathic vesicle-forming lipid derivatized with polyethyleneglycol,... Metselaar, Josbert...
由欧洲药品管理局(EMA)发布的关于Clinical investigation of medicinal products in the treatment of lipid disorders (Rev. 1 and 2)(治疗血脂异常药物的临床调研(Rev. 1 and 2)),来源于药智数据政策法规数据库。
D. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences. Kidney Int. 90, 41–52 (2016). Article CAS PubMed PubMed Central Google Scholar Joven, J. et al. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome. N. Engl. J. Med. 323, ...
lipid disorders induced by a high-fat. It can increase the abundance of intestinal flora and restore the composition of intestinal microbes [75]. In addition, supplemented with hawthorn concentrated juice (10, 15, 20 ml/kg) for 5 weeks, the contents of TC, TG, LDL-C, and very low-...
Lipid-based RNA nanocarriers have been recently accepted as a novel therapeutic option in humans, thus increasing the therapeutic options for patients. Tailored nanomedicines will enable to treat chronic liver disease (CLD) and end-stage liver cancer, disorders with high mortality and few treatment op...
LDL stands for "low-density lipoprotein," the type known as "bad" cholesterol. It causes buildup in your arteries. Too much of it can lead to heart disease. Triglycerides are another type of lipid. This is the most common type of fat in your body. They mostly come from foods you eat...
However, long-term treatment with antipsychotics is associated with a variety of movement disorders, the most disabling of which is tardive dyskinesia (TD), which occurs in up to 50% of patients hospitalized with chronic schizophrenia. The pathophysiology of TD is still unclear and no definite ...